Synovial explant inflammatory mediator production corresponds to rheumatoid arthritis imaging hallmarks: A cross-sectional study

Arthritis Research and Therapy

Volumn 16, Issue 3, 2014, Pages

  Andersen, Martin ^a,b   Boesen, Mikael ^a   Ellegaard, Karen ^a   Christensen, Robin ^a   Söderström, Kalle ^b   Søe, Niels ^c   Spee, Pieter ^b   Mørch, Ulrik G W ^b   Torp Pedersen, Søren ^a   Bartels, Else M ^a   Danneskiold Samsøe, Bente ^a   Vendel, Nina ^c   Karlsson, Lars ^b   Bliddal, Henning ^a  

^a Mental Health Services CPH   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; INTERLEUKIN 6; INTERLEUKIN 8; LEFLUNOMIDE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; RITUXIMAB; SALAZOSULFAPYRIDINE; AUTACOID;

ADULT; ARTHROSCOPY; ARTICLE; BONE EROSION; BONE MARROW EDEMA; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DAS28; DISEASE ACTIVITY; DISEASE DURATION; EXPLANT; FEMALE; HAND JOINT; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; MALE; MEDIATOR RELEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROXIMAL INTERPHALANGEAL JOINT; REMISSION; RHEUMATOID ARTHRITIS; SYNOVECTOMY; SYNOVITIS; SYNOVIUM; WRIST; AGED; ECHOGRAPHY; IMMUNOASSAY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHEMOKINE CCL4; CROSS-SECTIONAL STUDIES; FEMALE; HAND JOINTS; HUMANS; IMMUNOASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNOVIAL MEMBRANE; SYNOVITIS; TISSUE CULTURE TECHNIQUES; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84902659907     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4557     Document Type: Article

References (44)

1. Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Den Broeder AA, van Riel P, Fransen J, van de Laar MAFJ. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry. Ann Rheum Dis 2012, 71:845-850. 10.1136/annrheumdis-2011-200274, 22210852.
2. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, Gorter S, Knevel R, Nam J, Schoels M, Aletaha D, Buch M, Gossec L, Huizinga T, Bijlsma JW, Burmester G, Combe B, Cutolo M, Gabay C, Gomez-Reino J, Kouloumas M, Kvien TK, Martin-Mola E, McInnes I, Pavelka K, van Riel P, Scholte M, Scott DL, Sokka T, Valesini G, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010, 69:964-975. A published erratum appears in Ann Rheum Dis 2011, 70:1519., 10.1136/ard.2009.126532, 2935329, 20444750.
3. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006, 54:3761-3773. 10.1002/art.22190, 17133543.
4. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008, 58:2958-2967. 10.1002/art.23945, 18821687.
5. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581. 10.1002/art.27584, 20872595.
6. Haavardsholm EA, Bøyesen P, Østergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 2008, 67:794-800. 10.1136/ard.2007.071977, 17981915.
7. Østergaard M, Edmonds J, McQueen F, Peterfy C, Lassere M, Ejbjerg B, Bird P, Emery P, Genant H, Conaghan P. An introduction to the EULAR-OMERACT rheumatoid arthritis MRI reference image atlas. Ann Rheum Dis 2005, 64:i3-i7. 10.1136/ard.2004.031773, 1766828, 15647420.
8. Peterfy C, Østergaard M, Conaghan PG. MRI comes of age in RA clinical trials. Ann Rheum Dis 2013, 72:794-796. 10.1136/annrheumdis-2012-202696, 23345597.
9. Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 2005, 64:834-838. 10.1136/ard.2004.029751, 1755544, 15576415.
10. Gaffney K, Cookson J, Blake D, Coumbe A, Blades S. Quantification of rheumatoid synovitis by magnetic resonance imaging. Arthritis Rheum 1995, 38:1610-1617. 10.1002/art.1780381113, 7488282.
11. Østergaard M, Stoltenberg M, Løvgreen-Nielsen P, Volck B, Jensen CH, Lorenzen I. Magnetic resonance imaging-determined synovial membrane and joint effusion volumes in rheumatoid arthritis and osteoarthritis: comparison with the macroscopic and microscopic appearance of the synovium. Arthritis Rheum 1997, 40:1856-1867. 10.1002/art.1780401020, 9336422.
12. Axelsen MB, Stoltenberg M, Poggenborg RP, Kubassova O, Boesen M, Bliddal H, Hørslev-Petersen K, Hanson LG, Østergaard M. Dynamic gadolinium-enhanced magnetic resonance imaging allows accurate assessment of the synovial inflammatory activity in rheumatoid arthritis knee joints: a comparison with synovial histology. Scand J Rheumatol 2012, 41:89-94. 10.3109/03009742.2011.608375, 22283139.
13. Bugatti S, Manzo A, Caporali R, Montecucco C. Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective. Arthritis Res Ther 2012, 14:229. 10.1186/ar4115, 3674615, 23270711.
14. Dalbeth N, Smith T, Gray S, Doyle A, Antill P, Lobo M, Robinson E, King A, Cornish J, Shalley G, Gao A, McQueen FM. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis 2009, 68:279-282. 10.1136/ard.2008.096024, 18765428.
15. Jimenez-Boj E, Nöbauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, Trattnig S, Axmann R, Tsuji W, Hermann S, Smolen J, Schett G. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007, 56:1118-1124. 10.1002/art.22496, 17393390.
16. Chabaud M, Miossec P. The combination of tumor necrosis factor α blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum 2001, 44:1293-1303. 10.1002/1529-0131(200106)44:6<1293::AID-ART221>3.0.CO;2-T, 11407688.
17. Chevrel G, Garnero P, Miossec P. Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor α soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3α and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation. Ann Rheum Dis 2002, 61:730-733. 10.1136/ard.61.8.730, 1754206, 12117682.
18. Hosaka K, Ryu J, Saitoh S, Ishii T, Kuroda K, Shimizu K. The combined effects of anti-TNFα antibody and IL-1 receptor antagonist in human rheumatoid arthritis synovial membrane. Cytokine 2005, 32:263-269. 10.1016/j.cyto.2005.11.005, 16406555.
19. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 1992, 35:874-883. 10.1002/art.1780350805, 1642654.
20. Miossec P, Chomarat P, Dechanet J, Moreau JF, Roux JP, Delmas P, Banchereau J. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. Arthritis Rheum 1994, 37:1715-1722. 10.1002/art.1780371202, 7986216.
21. Schultz O, Keyszer G, Zacher J, Sittinger M, Burmester GR. Development of in vitro model systems for destructive joint diseases: novel strategies for establishing inflammatory pannus. Arthritis Rheum 1997, 40:1420-1428. 10.1002/art.1780400809, 9259421.
22. Ounissi-Benkalha H, Pelletier JP, Tardif G, Mineau F, Jolicoeur FC, Ranger P, Martel-Pelletier J. In vitro effects of 2 antirheumatic drugs on the synthesis and expression of proinflammatory cytokines in synovial membranes from patients with rheumatoid arthritis. J Rheumatol 1996, 23:16-23.
23. Volin MV, Campbell PL, Connors MA, Woodruff DC, Koch AE. The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production. Exp Mol Pathol 2002, 73:84-92. 10.1006/exmp.2002.2460, 12231210.
24. Nic an Ultaigh S, Saber TP, McCormick J, Connolly M, Dellacasagrande J, Keogh B, McCormack W, Reilly M, O'Neill LA, McGuirk P, Fearon U, Veale DJ. Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther 2011, 13:R33. 10.1186/ar3261, 3241377, 21345222.
25. van de Sande MG, Gerlag DM, Lodde BM, van Baarsen LG, Alivernini S, Codullo V, Felea I, Vieira-Sousa E, Fearon U, Reece R, Montecucco C, Veale DJ, Pitzalis C, Emery P, Klareskog L, McInnes IB, Tak PP. Evaluating antirheumatic treatments using synovial biopsy: a recommendation for standardisation to be used in clinical trials. Ann Rheum Dis 2011, 70:423-427. 10.1136/ard.2010.139550, 21109518.
26. Scirè CA, Epis O, Codullo V, Humby F, Morbini P, Manzo A, Caporali R, Pitzalis C, Montecucco C. Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure. Arthritis Res Ther 2007, 9:R101. 10.1186/ar2302, 2212566, 17903238.
27. Todd DJ, Knowlton N, Amato M, Frank MB, Schur PH, Izmailova ES, Roubenoff R, Shadick NA, Weinblatt ME, Centola M, Lee DM. Erroneous augmentation of multiplex assay measurements in patients with rheumatoid arthritis due to heterophilic binding by serum rheumatoid factor. Arthritis Rheum 2011, 63:894-903. 10.1002/art.30213, 21305505.
28. Qvistgaard E, Røgind H, Torp-Pedersen S, Terslev L, Danneskiold-Samsøe B, Bliddal H. Quantitative ultrasonography in rheumatoid arthritis: evaluation of inflammation by Doppler technique. Ann Rheum Dis 2001, 60:690-693. 10.1136/ard.60.7.690, 1753744, 11406524.
29. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Jr Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
30. Cuellar VG, Cuellar JM, Golish SR, Yeomans DC, Scuderi GJ. Cytokine profiling in acute anterior cruciate ligament injury. Arthroscopy 2010, 26:1296-1301. 10.1016/j.arthro.2010.02.011, 20887928.
31. Terslev L, von der Recke P, Torp-Pedersen S, Koenig MJ, Bliddal H. Diagnostic sensitivity and specificity of Doppler ultrasound in rheumatoid arthritis. J Rheumatol 2008, 35:49-53.
32. Torp-Pedersen ST, Terslev L. Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology. Ann Rheum Dis 2008, 67:143-149. 10.1136/ard.2007.078451, 18055471.
33. Ellegaard KM, Torp-Pedersen S, Christensen R, Stoltenberg M, Hansen A, Lorenzen T, Jensen DV, Lindegaard H, Juul L, Røgind H, Bülow P, Chrysidis S, Kowalski M, Danneskiold-Samsøe B, Bliddal H. Feasibility of a standardized ultrasound examination in patients with rheumatoid arthritis: a quality improvement among rheumatologists cohort. BMC Musculoskelet Disord 2012, 13:35. 10.1186/1471-2474-13-35, 3414749, 22410241.
34. Laurell L, Court-Payen, Nielsen S, Zak M, Boesen M, Fasth A. Comparison of ultrasonography with Doppler and MRI for assessment of disease activity in juvenile idiopathic arthritis: a pilot study. Pediatr Rheumatol Online J 2012, 10:23. 10.1186/1546-0096-10-23, 3608365, 22897976.
35. Andersen M, Ellegaard K, Hebsgaard JB, Christensen R, Torp-Pedersen S, Kvist PH, Søe N, Rømer J, Vendel N, Bartels EM, Danneskiold-Samsøe B, Bliddal H. Ultrasound colour Doppler is associated with synovial pathology in biopsies from hand joints in rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis 2014, 73:678-683. 10.1136/annrheumdis-2012-202669, 23475981.
36. Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, Matsushima K, Stengaard-Pedersen K. Localisation of interleukin 8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol 1994, 23:2-7. 10.3109/03009749409102126, 8108662.
37. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992, 31:653-661. 10.1093/rheumatology/31.10.653, 1393370.
38. Mulherin D, FitzGerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 1996, 39:115-124. 10.1002/art.1780390116, 8546720.
39. Katschke KJ, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Arthritis Rheum 2001, 44:1022-1032. 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N, 11352233.
40. Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE, . ATTRACT Study Group Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum 2005, 52:1020-1030. 10.1002/art.20982, 15818697, ATTRACT Study Group.
41. Landewé R, van der Heijde D, Klareskog L, van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006, 54:3119-3125. 10.1002/art.22143, 17009230.
42. Semerano L, Gutierrez M, Falgarone G, Filippucci E, Guillot X, Boissier MC, Grassi W. Diurnal variation of power Doppler in metacarpophalangeal joints of patients with rheumatoid arthritis: a preliminary study. Ann Rheum Dis 2011, 70:1699-1700. 10.1136/ard.2010.146761, 21482535.
43. Kontny E, Plebanczyk M, Lisowska B, Olszewska M, Maldyk P, Maslinski W. Comparison of rheumatoid articular adipose and synovial tissue reactivity to proinflammatory stimuli: contribution to adipocytokine network. Ann Rheum Dis 2012, 71:262-267. 10.1136/annrheumdis-2011-200123, 21989538.
44. Nozaki T, Takahashi K, Ishii O, Endo S, Hioki K, Mori T, Kikukawa T, Boumpas DT, Ozaki S, Yamada H. Development of an ex vivo cellular model of rheumatoid arthritis: critical role of CD14-positive monocyte/macrophages in the development of pannus tissue. Arthritis Rheum 2007, 56:2875-2885. 10.1002/art.22849, 17763413.